ID   UOK146
AC   CVCL_B123
SY   UOK-146; UOK 146
DR   Cosmic; 1330968
DR   Wikidata; Q54991378
RX   PubMed=8872474;
RX   PubMed=9255309;
CC   Sequence variation: Gene fusion; HGNC; HGNC:9343; PRCC + HGNC; HGNC:11752; TFE3; Name(s)=PRCC-TFE3 (PubMed=8872474).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=8872474; DOI=10.1093/hmg/5.9.1333;
RA   Sidhar S.K., Clark J., Gill S., Hamoudi R., Crew A.J., Gwilliam R.,
RA   Ross M., Linehan W.M., Birdsall S., Shipley J.M., Cooper C.S.;
RT   "The t(X;1)(p11.2;q21.2) translocation in papillary renal cell
RT   carcinoma fuses a novel gene PRCC to the TFE3 transcription factor
RT   gene.";
RL   Hum. Mol. Genet. 5:1333-1338(1996).
//
RX   PubMed=9255309; DOI=10.1016/S0090-4295(97)00220-3;
RA   Walther M.M., Kleiner D.E., Lubensky I.A., Pozzatti R., Nyguen T.,
RA   Gnarra J.R., Hurley K., Venzon D., Linehan W.M.,
RA   Stetler-Stevenson W.G.;
RT   "Progelatinase A mRNA expression in cell lines derived from tumors in
RT   patients with metastatic renal cell carcinoma correlates inversely
RT   with survival.";
RL   Urology 50:295-301(1997).
//